Guidance for Intra-cellular Therapies, Inc. (ITCI)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2024 | N/A | N/A | $650.00M – 680.00M | $662.20M | = Maintained | Details |
| 2024 | N/A | N/A | $645.00M – 675.00M | $661.70M | = Maintained | Details |
| 2024 | N/A | N/A | $645.00M – 675.00M | $656.40M | = Maintained | Details |
| Q4 2024 | N/A | N/A | $665.00M – 685.00M | $666.60M | = Maintained | Details |
| 2023 | N/A | N/A | $430.00M – 455.00M | $448.00M | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
